These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 18547788

  • 1. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY, Takeuchi S, Moroi Y, Hayashida S, Kido M, Chen SJ, Tomoeda H, Uenotsuchi T, Tu YT, Furue M, Urabe K.
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract] [Full Text] [Related]

  • 2. Immunohistochemical profiling of Wnt, NF-kappaB, Stat3 and Notch signaling in human epidermal tumors.
    Liu ZL, Li Y, Kong QY, Zhan C, Wang Q, Chen XY, Sun Y, Wen S, Tu CX, Liu J, Li H.
    J Dermatol Sci; 2008 Nov; 52(2):133-6. PubMed ID: 18703315
    [No Abstract] [Full Text] [Related]

  • 3. Significance of the expression of phosphorylated-STAT3, -Akt, and -ERK1/2 in several tumors of the epidermis.
    Lin N, Moroi Y, Uchi H, Fukiwake N, Dainichi T, Takeuchi S, Takahara M, Tu Y, Furue M, Urabe K.
    J Dermatol Sci; 2007 Oct; 48(1):71-3. PubMed ID: 17686614
    [No Abstract] [Full Text] [Related]

  • 4. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y, Kubo Y, Murao K, Arase S.
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR, Min SK, Min K, Jun SY, Seo J, Kim KH, Choi J.
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [Abstract] [Full Text] [Related]

  • 6. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
    Kai H, Kadono T, Kakinuma T, Tomita M, Ohmatsu H, Asano Y, Tada Y, Sugaya M, Sato S.
    Pathol Res Pract; 2011 Jan 15; 207(1):43-8. PubMed ID: 21144674
    [Abstract] [Full Text] [Related]

  • 7. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
    Wang Q, Ma H, Wang S, Ma Y, Zou X, Li R.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul 15; 33(7):1075-7. PubMed ID: 23895857
    [Abstract] [Full Text] [Related]

  • 8. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH, Robinson RA.
    Mod Pathol; 1995 Jun 15; 8(5):526-9. PubMed ID: 7675772
    [Abstract] [Full Text] [Related]

  • 9. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX, Peng ZH, Ji FP, Yuan JY, Pan M, Liu Y, Wang Q.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug 15; 26(8):1245-7. PubMed ID: 16939929
    [Abstract] [Full Text] [Related]

  • 10. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH, Yang SA, Wang JY, Yu HS, Lin SR.
    Br J Cancer; 1999 Jun 15; 80(7):1080-6. PubMed ID: 10362120
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M, Furihata M, Kurabayashi A, Ohtsuki Y.
    Oncol Rep; 2004 Nov 15; 12(5):1039-43. PubMed ID: 15492790
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
    Takeda A, Nonaka M, Ishikawa A, Higuchi D.
    Arch Dermatol Res; 1999 Apr 15; 291(4):238-40. PubMed ID: 10335922
    [No Abstract] [Full Text] [Related]

  • 13. Increased expression of activating transcription factor 3 is related to the biologic behavior of cutaneous squamous cell carcinomas.
    Kim MS, In SG, Park OJ, Won CH, Lee MW, Choi JH, Kim CW, Kim SE, Moon KC, Chang S.
    Hum Pathol; 2011 Jul 15; 42(7):954-9. PubMed ID: 21315420
    [Abstract] [Full Text] [Related]

  • 14. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K, Uno K, Kuwabara H, Kojima K, Ohno S, Sakurai H, Kamma H, Kurata A.
    Pathol Res Pract; 2014 Oct 15; 210(10):634-9. PubMed ID: 24939142
    [Abstract] [Full Text] [Related]

  • 15. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
    O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E.
    Histopathology; 2007 Dec 15; 51(6):793-804. PubMed ID: 18042068
    [Abstract] [Full Text] [Related]

  • 16. All Bowen's disease is squamous cell carcinoma in situ, but all squamous cell carcinoma in situ is not Bowen's disease.
    Martin AA, Hudgins EM, McMullan FH.
    J Cutan Pathol; 2010 Nov 15; 37(11):1186-7. PubMed ID: 20579212
    [No Abstract] [Full Text] [Related]

  • 17. P16(INK4A) expression in Bowen's disease and Bowenoid papulosis.
    Auepemkiate S, Thongsuksai P, Boonyaphiphat P.
    J Med Assoc Thai; 2006 Sep 15; 89(9):1460-5. PubMed ID: 17100385
    [Abstract] [Full Text] [Related]

  • 18. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
    Jang TJ.
    Yonsei Med J; 2002 Jun 15; 43(3):304-8. PubMed ID: 12089736
    [Abstract] [Full Text] [Related]

  • 19. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
    Ito T, Tsuji G, Ohno F, Nakahara T, Uchi H, Furue M.
    Mod Pathol; 2017 Jul 15; 30(7):919-927. PubMed ID: 28339425
    [Abstract] [Full Text] [Related]

  • 20. [Epidermoid carcinomas].
    Ortonne N.
    Ann Dermatol Venereol; 2003 Jul 15; 130(6-7):667-9. PubMed ID: 13679711
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.